Delivering Commercial-Scale
Quantum Computing
A Company Built to
Deliver at Scale
Quantum computing is poised to accelerate drug discovery, enhance financial modelling, transform cryptography, optimize logistics, and enable breakthroughs in materials science and climate simulations. Photonic will be at the forefront of these transformative changes with the world’s first commercial-scale, fault-tolerant quantum computer based on an innovative qubit modality built to scale.
Photonic grew out of an ambitious vision—to engineer a scalable solution for quantum computing from the ground up. Dr. Stephanie Simmons and Dr. Michael Thewalt were convinced that a fundamentally different approach would be required to support transformative quantum applications at scale. These applications require huge quantities of connected, error-corrected qubits, orchestrated to complete complex operations at any one time. Photonic was founded in 2016, capturing their research into silicon T centres that demonstrate unique properties and marking the start of a new approach to quantum computing.
Commercialization efforts began in 2021, moving quickly from concept to system manufacturing. Photonic’s Entanglement First™ architecture guides the development of our quantum computing platform. Every component is designed to scale up and scale out, enabling high-performance quantum computing with cost-efficient manufacturability and a compact footprint.
The Best of the Best
from Around the World
Photonic’s team combines deep expertise in quantum science with proven experience in high-performance computing and complex system development. This is a team with a track record of turning breakthrough technologies into commercial-scale platforms.
Headquartered in Vancouver, Canada, and spanning North America, the UK, and Europe, more than 160 experts and seasoned executives are focused on building the foundation for distributed quantum computing at scale.
Executive Team
Innovators experienced in
delivering disruptive technologies

Dr. Paul Terry

Dr. Stephanie Simmons

Sarah Boatman

Kirsten Sutton

Alison Berg

Dr. Klaus Schuegraf

Neysa Finnie

Jessi Hodgson

Nick Morris
Board of Directors
Driving effective governance

Gordon Fyfe

Nanon de Gaspé Beaubien-Mattrick

Dr. Hermann Hauser

Nathan Medlock

Lorrie Norrington

Dr. Stephanie Simmons

Dr. Paul Terry
Scientific Fellows
Experts in quantum and AI
Our Investors












